Mesangial Cells and Glomerular Inflammation: From the Pathogenesis to Novel Therapeutic Approaches

Publisher： Bentham Science Publishers

E-ISSN： 1875-5933|4|3|341-351

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.4, Iss.3, 2005-06, pp. : 341-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Therapeutic Approaches in Limiting Oxidative Stress and Inflammation

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 13, 2012-10 ,pp. : 2456-2466

Bentham Science Publishers

Access to resources Recommend Favorite

Losartan inhibits STAT1 activation and protects human glomerular mesangial cells from angiotensin II induced premature senescence

By Jiao Sumin   Zheng Xiaoyu   Yang Xue   Zhang Jin   Wang Lining  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 1, 2012-01 ,pp. : 89-98

NRC Research Press

Access to resources Recommend Favorite

Cyclic AMP inhibits stretch-induced overexpression of fibronectin in glomerular mesangial cells

By Nishio T.   Haneda M.   Koya D.   Inoki K.   Maeda S.   Kikkawa R.  

European Journal of Pharmacology, Vol. 437, Iss. 3, 2002-02 ,pp. : 113-122

Elsevier

Access to resources Recommend Favorite

Inflammation in Hypertension: Current Therapeutic Approaches

By  

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-01 ,pp. : 4121-4131

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric oxide donors induce apoptosis in glomerular mesangial cells, epithelial cells and endothelial cells

By Muhl H.   Sandau K.   Brune B.   Briner V.A.   Pfeilschifter J.  

European Journal of Pharmacology, Vol. 317, Iss. 1, 1996-12 ,pp. : 137-149

Elsevier

Access to resources Recommend Favorite